---
$id: https://graph.org.ai/products/commodity/51172007
$type: Product
source: UNSPSC
code: "51172007"
title: "Azintamide"
class: "51172000"
classTitle: "Drugs used for gallbladder disease"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Azintamide

**UNSPSC Code**: 51172007
**Class**: [Drugs used for gallbladder disease](Drugs used for gallbladder disease.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholagogue or choleretic agent with the molecular formula C10H14ClN3OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ACZ6L64B41, chemically known as 2-((6-chloro-3-pyridazinyl)thio)-n,n-diethylacetamide but generally known as azintamide, which bears US NIH Compound Identifier 71105. European Medicines Agency schedules Azintamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05658MIG. The term AZINTAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). AZINTAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azintamide under HS 29339990 and SITC 51577. As of Q4 2014, AZINTAMIDE remains the US FDA Preferred Term for this commodity. Azintamide bears US NLM identifiers UMLS ID C1321999 and NCI Concept Code C74232. SMILES: CCN(CC)C(=O)CSC1=NN=C(C=C1)CL.

